insights_auto
Prečo akcie TMCI klesli 4,24%?
Preskúmať podrobnejšiechevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
4,29 USD
arrow_downward
-4,24%(-0,19) 1 d.
6. 10., 11:04:31 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre TMCI…
Otvoriť
4,53 USD
Vysoká
4,53 USD
Nízka
4,29 USD
Trh. kap.
273,39 mil.
Priem. obj.
235,91 tis.
Objem
21,60 tis.
Max. za 52 týž.
7,08 USD
Min. za 52 týž.
1,17 USD
Výnosy na akciu
-0,93 USD
Beta
1,48
Akcie v obehu
65,04 mil.
Počet zamestnancov
450
Otvoriť
4,53 USD
Vysoká
4,53 USD
Nízka
4,29 USD
Trh. kap.
273,39 mil.
Priem. obj.
235,91 tis.
Objem
21,60 tis.
Max. za 52 týž.
7,08 USD
Min. za 52 týž.
1,17 USD
Výnosy na akciu
-0,93 USD
Beta
1,48
Akcie v obehu
65,04 mil.
Počet zamestnancov
450
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
The Daily Tribune News
·
pred 40 minútami
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Option Care Health, Inc. (Nasdaq – OPCH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX), Sangoma Technologies C
Yahoo Finance
·
pred 55 minútami
The 3 tech stocks accounting for over 20% of the S&P 500
The Lufkin Daily News
·
pred 54 minútami
FILE PHOTO: Traders react to the Fed rate announcement on the floor of the NYSE in New York
CNBC
·
pred 1 hodinou
Opening Bell: October 6, 2026
Profil
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Informácie o subjekte Treace Medical Concepts, Inc